Our top pick for
Ichor Holdings, Ltd is a semiconductor equipment & materials business based in the US. Ichor shares (ICHR) are listed on the NASDAQ and all prices are listed in US Dollars. Ichor employs 1,355 staff and has a trailing 12-month revenue of around USD$858.6 million.
|Latest market close||USD$36.29|
|52-week range||USD$13.68 - USD$39.68|
|50-day moving average||USD$30.9929|
|200-day moving average||USD$27.0015|
|Wall St. target price||USD$38.86|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.234|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-13)||-1.97%|
|1 month (2020-12-18)||16.73%|
|3 months (2020-10-20)||49.40%|
|6 months (2020-07-20)||25.44%|
|1 year (2020-01-17)||-5.94%|
|2 years (2019-01-18)||88.03%|
|3 years (2018-01-19)||12.04%|
|5 years (2016-01-16)||N/A|
Valuing Ichor stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ichor's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ichor's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Ichor shares trade at around 25x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Ichor's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.29. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ichor's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Ichor's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$58.4 million.
The EBITDA is a measure of a Ichor's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$858.6 million|
|Operating margin TTM||4.07%|
|Gross profit TTM||USD$86.4 million|
|Return on assets TTM||3.93%|
|Return on equity TTM||12.43%|
|Market capitalisation||USD$849.4 million|
TTM: trailing 12 months
There are currently 1.0 million Ichor shares held short by investors – that's known as Ichor's "short interest". This figure is 6.2% down from 1.1 million last month.
There are a few different ways that this level of interest in shorting Ichor shares can be evaluated.
Ichor's "short interest ratio" (SIR) is the quantity of Ichor shares currently shorted divided by the average quantity of Ichor shares traded daily (recently around 483359.72222222). Ichor's SIR currently stands at 2.16. In other words for every 100,000 Ichor shares traded daily on the market, roughly 2160 shares are currently held short.
However Ichor's short interest can also be evaluated against the total number of Ichor shares, or, against the total number of tradable Ichor shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ichor's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Ichor shares in existence, roughly 40 shares are currently held short) or 0.0439% of the tradable shares (for every 100,000 tradable Ichor shares, roughly 44 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ichor.
Find out more about how you can short Ichor stock.
We're not expecting Ichor to pay a dividend over the next 12 months.
Over the last 12 months, Ichor's shares have ranged in value from as little as $13.68 up to $39.68. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ichor's is 2.3747. This would suggest that Ichor's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Ichor Holdings, Ltd. engages in the design, engineering, and manufacture of fluid delivery subsystems and components for semiconductor capital equipment. It primarily offers gas and chemical delivery subsystems that are used in the manufacturing of semiconductor devices. The company's gas delivery subsystems deliver, monitor, and control gases used in semiconductor manufacturing processes, such as etch and deposition; and chemical delivery subsystems blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes comprising chemical-mechanical planarization, electroplating, and cleaning. It also manufactures precision machined components, weldments, and proprietary products for use in fluid delivery systems. The company operates in the United States, Europe, Singapore, and internationally. Ichor Holdings, Ltd. was founded in 1999 and is headquartered in Fremont, California.
Everything we know about the Cloopen Group Holding Limited IPO, plus information on how to buy in.
Everything we know about the Decipher Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Proterra IPO, plus information on how to buy in.
Everything we know about the Grab IPO, plus information on how to buy in.
Everything we know about the Deliveroo IPO, plus information on how to buy in.
Everything we know about the Terns Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Angion Biomedica Corp IPO, plus information on how to buy in.
Everything we know about the PurposeBuilt Brands Inc IPO, plus information on how to buy in.
Everything we know about the LumiraDx Limited IPO, plus information on how to buy in.
Everything we know about the Vor Biopharma Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.